Krina Mehta is a translational and quantitative pharmacologist with over 15 years of industry experience advancing model-informed drug development (MIDD) strategies across therapeutic areas and modalities. Her work bridges biology, pharmacology, mathematics, and technology to enable efficient and science-driven development of safe and effective medicines.

She is deeply passionate about modernizing preclinical drug development through New Approach Methodologies (NAMs). Her vision is to strategically integrate NAMs—such as organ-on-chip systems, in silico models, and mechanistic simulations—into translational science frameworks to make drug development more efficient, ethical, and data-driven.

She currently serve as Director of Pharmacometrics and Quantitative Pharmacology at Kyowa Kirin, where she lead quantitative strategies to support preclinical-to-clinical translation and decision-making. She holds a PhD in Quantitative Pharmacology from Leiden University (The Netherlands), an MS in Pharmacometrics from the University of Maryland (USA), and a BPharm from Saurashtra University (India).

If you share an interest in quantitative modeling, NAMs, or translational pharmacology, follow us, connect with us, and share your NAM ideas and relevant work.